Edward Pershing
CEO, Director, 10% Owner · PROVECTUS BIOPHARMACEUTICALS, INC.
IndividualBuying only
- 2024
- Oct 13, 2026
- 50
Other insiders active in the same sector
No other insider has filed at Edward Pershing's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
- Framework Ventures IV L.P. - $42.62M in SDEV purchases and sales in the last 12 months
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
- Jesse J. Geiger - $41.11M in MEDP purchases and sales in the last 12 months
- Mark Hancock - $40.97M in PACS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Edward Pershing?
Edward Pershing is a corporate insider, tracked as CEO, Director, 10% Owner of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT). InsiderAlpha holds 50 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Edward Pershing submitted recently?
6 primary Form 4 filings in the last 90 days, covering 1 company.
Has Edward Pershing been buying or selling stock?
Recorded transactions: 2 open-market purchases ($330K) and 0 open-market sales across all tracked filings.